NR3C2 and cardiovascular disorder: Suppression of the renin-angiotensin-aldosterone system is therefore a key strategy in the treatment of chronic cardiovascular and renal disease and is achieved by the administration of ACEi, ARBs, and mineralocorticoid receptor antagonists, alone or in combination.